Dr. Stephan A. Grupp made history when he treated the first child with CAR T cell therapy, Emily Whitehead, who is now more than five years cancer-free. In CAR-T cell therapy, a patient’s own genetically altered immune cells fight cancer.

We learnt about the CAR-T cell research journey and FDA approval in our discussion with Dr. Carl June of University of Pennsylvania in the first episode of our CAR-T talk series.

In this episode, we are talking to Dr. Stephan A. Grupp who carried out the early pediatric trials and the global Novartis trial at CHOP leading to the FDA approval.

The discussion would focus on required preparations, recovery phase and where this treatment can be availed.

We will also be joined by Tom Whitehead, father of Emily Whitehead who will share his experience with the trial and progress of Emily post CAR-T cell therapy.